Stalevo (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Stalevo drug offered from Novartis Pharmaceuticals Corporation. This Aromatic Amino Acid [EPC],Amino Acids, Aromatic [Chemical/Ingredient],Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | carbidopa, levodopa, and entacapone |
| SUBSTANCE NAME: | CARBIDOPA; LEVODOPA; ENTACAPONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aromatic Amino Acid [EPC],Amino Acids, Aromatic [Chemical/Ingredient],Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-06-11 |
| END MARKETING DATE: | 0000-00-00 |
Stalevo HUMAN PRESCRIPTION DRUG Details:
| Item Description | Stalevo from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12.5; 50; 200(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2003-06-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0407_5ae03a7a-7282-4998-b111-2d81718fc058 |
| PRODUCT NDC: | 0078-0407 |
| APPLICATION NUMBER: | NDA021485 |
Other CARBIDOPA; LEVODOPA; ENTACAPONE Pharmaceutical Manufacturers / Labelers:
